Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.

@article{Di2019CanDC,
  title={Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study.},
  author={Ningning Di and Wenna Cheng and Xin-qing Jiang and Xinjiang Liu and Jinliang Zhou and Qian Xie and Z Chu and Huacheng Chen and Bin Wang},
  journal={Journal of neuroradiology. Journal de neuroradiologie},
  year={2019},
  volume={46 3},
  pages={
          186-192
        }
}
  • N. Di, W. Cheng, +6 authors Bin Wang
  • Published 1 May 2019
  • Medicine
  • Journal of neuroradiology. Journal de neuroradiologie
DCE-MRI in Glioma, Infiltration Zone and Healthy Brain to Assess Angiogenesis: A Biopsy Study
TLDR
The DCE-MRI kinetic parameters show correlations with microvascular parameters in vital tissue and also reveal blood-brain barrier abnormalities in the infiltration zones adequate to differentiate glioma prognostic groups.
Non-Invasive Estimation of Glioma IDH1 Mutation and VEGF Expression by Histogram Analysis of Dynamic Contrast-Enhanced MRI
TLDR
VEGF expression is significantly lower in IDH1mut gliomas as compared to the wildtype counterpart, and it is non-invasively predictable with histogram analysis of DCE-MRI.
Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Analysis of Microvascular Permeability in Peritumor Brain Edema of Fibrous Meningiomas
TLDR
DCE-magnetic resonance imaging can be used to quantify the microvascular permeability of PTBE in patients with meningioma and showed that tumor size ≥10 cm3 and Vp were independently associated with PTBE.
Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients
TLDR
DCE parameter evaluation and clinical feature comparison between the PTEN positive and negative groups were performed and correlation between PTEN expression with the PFS and prognosis status using Cox regression for survival analysis were assessed.
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Evaluate the Therapeutic Effect and Prognosis of Intracranial Gliomas (Preprint)
BACKGROUND Intracranial glioma is the most common primary malignant tumor, accounting for about half of all the primary malignant tumors in the brain, with a high rate of disability and death.
Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging
TLDR
The purpose of this article is to provide a comprehensive update on the techniques, protocols, and clinical applications – both established and emerging – of DCE in whole-body imaging.
Difuzní low grade gliomy – jak je správně diagnostikovat a efektivně léčit?
Difuzní nízkostupňové gliomy se typicky vyskytují u lidí v produktivním věku. Představují značné riziko objemové progrese spojené s neurologickým deficitem a zároveň riziko malignizace. Diagnostika a
...
1
2
...

References

SHOWING 1-10 OF 40 REFERENCES
Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits
TLDR
If Ktrans elevation is present, Ktrans-based biopsy targeting provides significantly more diagnostic tissue samples in non-contrast-enhancing glioma than selection based on CET1W and FLAIR-weighted images alone.
Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.
TLDR
DCE-MRI may facilitate noninvasive preoperative predictions of areas of tumor with increased hypoxia and proliferation and has the potential to allow unprecedented prognostic decisions and to guide therapies to specific tumor areas.
Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma
TLDR
DCE-MRI is a useful measure of early pharmacodynamic effects of VEGF Trap on tumor vasculature, and the absence of significant changes in FDG-PET and DW-MRI suggest that the early pharmacodynamics effects are specific to tumor perfusion and/or permeability and do not directly inhibit metabolism or induce cell death.
Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas
TLDR
After a single dose, Vtot was predictive of overall survival (OS), while VCE-T1 showed a tendency of correlation with OS, and tumor subvolumes with increased values of nIAUGC and Ktrans showed the potential for improving the diagnostic accuracy of DCE.
Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers
TLDR
DCE-MRI may be used to differentiate between high-grade and low-grade brain tumors non-invasively, which may be helpful in appropriate treatment planning and management of these patients.
Quantification of cerebral tumour blood flow and permeability with T1-weighted dynamic contrast enhanced MRI: a feasibility study.
TLDR
DCE-MRI-based quantitative perfusion and permeability may be helpful for tumor-grade characterization, biopsy guidance, radiotherapy planning, Radotherapy monitoring and clinical follow-up, thereby improving the non-invasive characterization of brain tumors.
Comparison of the Diagnostic Accuracy of DSC- and Dynamic Contrast-Enhanced MRI in the Preoperative Grading of Astrocytomas
TLDR
In the preoperative grading of astrocytomas, the diagnostic accuracy of dynamic contrast-enhanced MR imaging parameters is similar to that of relative CBV, and a phase-derived vascular input function and “bookend” T1 measurements with DSC MR imaging is used.
...
1
2
3
4
...